invoX aims to improve lives through the delivery of medicines. Our vision is to be a leading developer, manufacturer and supplier of complex respiratory drug-device combination and medicinal products to patients.
We have a diversified pipeline of promising clinical and pre-clinical stage drug candidates in respiratory therapeutics. We have developed innovative and generic drug-device combination products using a proprietary next-generation soft mist inhaler (SMI) platform, called Softhaler®. Softhaler® uses differentiated technology to deliver propellant-free liquid-based formulation to the lung.
Company Details
- Employees
- 70
- Founded
- -
- Address
- Bioville - Abis Building, Agoralaan, Diepenbeek,belgium
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://invoxpharma.com
- Keywords
- Healthcare, Pharmaceuticals, Biotech, Respiratory, Research and Development, Medicine Device.
- HQ
- Diepenbeek
Invox Questions
Invox's website is http://invoxpharma.com
Invox's LinkedIn profile is https://be.linkedin.com/company/invox-pharma
Invox has
70 employees.
View email and phone details for 70
employees at Invox.
Invox's industry is
Pharmaceutical Manufacturing
Invox's top competitors are
Astrazeneca,
Bicycle Therapeutics,
Sino Biopharmaceutical Limited,
Hengrui Pharma,
Artios,
Phion Therapeutics,
Invox Belgium (Formerly Softhale Nv),
F-Star Therapeutics,
Gsk,
Sino Biological, Inc..
Invox's categories are Pharmaceutical Manufacturing
Invox's founding year is 2021
